Anti-slobeta1 (KCNMB1)

Antibodies

Maxi potassium channel beta, MaxiKbeta, Ca2+-activated K+ channel subunit β1, BKCa subunit β1, BK beta1, Charybdotoxin receptor subunit beta-1, K(VCA)beta-1, Slowpoke-beta

Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C

Lyophilized powder. Reconstituted antibody contains phosphate buffered saline (PBS), pH 7.4

Maxi potassium channel beta, MaxiKbeta, Ca2+-activated K+ channel subunit β1, BKCa subunit β1, BK beta1, Charybdotoxin receptor subunit beta-1, K(VCA)beta-1, Slowpoke-beta - A Rabbit Polyclonal Antibody to slo?1 (KCNMB1) Subunit

Mouse, human, dog, rabbit - identical

Confirmed by amino acid analysis and mass spectrometry

0.8 mg/ml

Intracellular, N-terminal domain

Rat

41116161

sloβ1 is a member of a family of regulatory β subunits that control the activity of the large conductance Ca2+-activated K+ channel KCa1.1. The family includes four members with a shared topology: two trans-membrane domains, short intracellular N- and C-termini and a large extracellular region. The four members of the family have a distinct tissue distribution with sloβ1 expressed almost exclusively in smooth muscle.Functionally, sloβ1 increases the sensitivity of the pore-forming KCa1.1 subunit to Ca2+ and voltage and it also changes its pharmacology.In the past few years there has been a lot of interest regarding the role of the sloβ1 subunit in the regulation of vascular tone and hypertension. Studies in sloβ1 knockout mice have shown that loss of this subunit results in systemic hypertension. Conversely, a recent study showed that a commonly found gain-of-function sloβ1 variant has a protective effect against human diastolic hypertension.